Newsroom | 1712 results

PHILADELPHIA--(BUSINESS WIRE)--In recognition of National Condom Month, sex and relationship therapist Dr. Deb Laino is encouraging young adults to prioritize safer sex practices - not just for protection, but for the emotional and relational benefits that come with feeling secure and aligned with your partner. As conversations around consent and sexual wellness continue to evolve, Dr. Laino emphasizes that condoms are not just about prevention - they help create a shared understanding of respo...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AHF Sues FL Health Dept. to Block Emergency Rule Cutting HIV Drug Access for Thousands...

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--AHF to President Trump: Save Florida's AIDS Drug Assistance Program!...

TALLAHASSEE, Fla.--(BUSINESS WIRE)--This morning AIDS Healthcare Foundation (AHF) filed an administrative action to challenge the validity of the emergency rule enacted by the Florida Department of Health, prior to a hearing scheduled yesterday morning with State Administrative Law Judge W. David Watkins. The Florida Department of Health has invoked emergency powers designed to protect public health in order to cut 16,000 Floridians off their HIV medications. On the eve of a court hearing chall...

FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Grammy, Emmy, Golden Globe, NAACP, SAG and Critic’s Choice award-winning and Oscar-nominated musician, actress, producer, label president, author and entrepreneur will headline AIDS Healthcare Foundation’s 21st Annual Florida AIDS Walk & Music Festival presented by AHF Pharmacy, Fed Ex and Wells Fargo at Fort Lauderdale Beach on Saturday, March 21, 2026. The annual 5k walk and concert, which recently celebrated its 20th anniversary, has raised millions...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced positive 12-month interim efficacy and tolerability data from the phase IIb EMBRACE study.1 In adults living with HIV on stable therapy, a regimen of lotivibart (N6LS), a broadly neutralising antibody, administered every four months combined with monthly intramuscular (IM) long-acting cabotegravir (CAB LA), maintained viral suppression in...

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced data from its phase 1 study of long-acting formulations of VH184, the first, third-generation integrase strand transfer inhibitor (INSTI) in development for HIV.1 Results show a single-dose injection could maintain drug levels for up to six months. In-vitro data from a separate study demonstrate improved potency and an enhanced resistance...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at CROI 2026 showing a treatment switch to an investigational, single-tablet combination regimen of bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN) was effective in people living with HIV with virological suppression, including those switching from complex multi-tablet regimens or a global guideline-recommended single-tablet regimen. The n...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), a Once-Daily, Two-Drug Regimen at CROI 2026...

TALLAHASSEE, Fla.--(BUSINESS WIRE)--An Administrative Law Judge today ordered an emergency hearing for Wednesday, February 25, in AIDS Healthcare Foundation's legal challenge to the Florida Department of Health's plan to slash eligibility for the state's AIDS Drug Assistance Program, known as ADAP. Beginning March 1, the Department plans to cut the qualifying income for the program from roughly $62,600 to $21,000 for an individual, dropping thousands of Floridians living with HIV from the cover...